| Biotechnology Industry | Healthcare Sector | Mr. Yongbo Song CEO | SSE Exchange | - ISIN |
| CN Country | 1,759 Employees | 27 Jun 2025 Last Dividend | 2 Jun 2022 Last Split | - IPO Date |
Shenzhen YHLO Biotech Co., Ltd. is a prominent entity in the biotechnology industry, engaging in the research, development, production, sales, and servicing of in vitro diagnostic instruments and reagents. Since its inception in 2008, the company has built a strong international and domestic presence, operating from its headquarters in Shenzhen, China. It focuses on delivering innovative diagnostic solutions across a wide range of medical and scientific fields, catering to the growing global demand for accurate and reliable diagnostic technologies.